Abstract
This prospective double-blinded randomized controlled trial compared metoclopramide and promethazine in the treatment of hyperemesis gravidarum. Participants in the study were women admitted to the Gynecology ward at a university hospital in Kuala Lumpur, Malaysia who had dehydration and detectable ketonuria, were under 16 weeks gestation, and did not have another known cause of nausea and vomiting. All patients received intravenous hydration. Patients in both treatment groups had similar primary outcomes, including well-being measured on a visual numerical rating scale and frequency of vomiting in the first 24 h. Patients also had similar secondary outcomes, including nausea as measured on a visual numerical rating scale and persistence of ketonuria at 24 h. However, patients in the promethazine arm had significantly greater occurrence of adverse events, including drowsiness (p=0.001), dizziness (p<0.001), and dystonia (p=0.02).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
